> 0 1 0 1 O
= 1 2 1 2 O
140 3 6 3 6 B-lower_bound
mmHg 7 11 7 11 I-lower_bound
or 12 14 12 14 O
diastolic 15 24 15 24 B-clinical_variable
blood 25 30 25 30 I-clinical_variable
pressure 31 39 31 39 I-clinical_variable
( 40 41 40 41 I-clinical_variable
DBP 41 44 41 44 I-clinical_variable
) 44 45 44 45 I-clinical_variable
of 46 48 46 48 O
> 49 50 49 50 O
= 50 51 50 51 O
90mmHg 52 58 52 58 B-lower_bound

A 0 1 59 60 O
bilateral 2 11 61 70 B-treatment
oophorectomy 12 24 71 83 I-treatment
( 25 26 84 85 O
ovariectomy 26 37 85 96 B-treatment
) 37 38 96 97 O

A 0 1 98 99 O
hysterectomy 2 14 100 112 B-treatment

Absolute 0 8 113 121 B-clinical_variable
neutrophil 9 19 122 132 I-clinical_variable
count 20 25 133 138 I-clinical_variable
( 26 27 139 140 I-clinical_variable
ANC 27 30 140 143 I-clinical_variable
) 30 31 143 144 I-clinical_variable
> 32 33 145 146 O
= 33 34 146 147 O
1.5 35 38 148 151 B-lower_bound
x 39 40 152 153 I-lower_bound
10 41 43 154 156 I-lower_bound
^ 43 44 156 157 I-lower_bound
9 44 45 157 158 I-lower_bound
/ 45 46 158 159 I-lower_bound
L 46 47 159 160 I-lower_bound

Activated 0 9 161 170 B-clinical_variable
partial 10 17 171 178 I-clinical_variable
thromboplastin 18 32 179 193 I-clinical_variable
time 33 37 194 198 I-clinical_variable
( 38 39 199 200 I-clinical_variable
aPTT 39 43 200 204 I-clinical_variable
) 43 44 204 205 I-clinical_variable
= 45 46 206 207 O
< 46 47 207 208 O
1.2 48 51 209 212 B-upper_bound
x 52 53 213 214 I-upper_bound
ULN 54 57 215 218 I-upper_bound

Active 0 6 219 225 B-chronic_disease
peptic 7 13 226 232 I-chronic_disease
ulcer 14 19 233 238 I-chronic_disease
disease 20 27 239 246 I-chronic_disease

Adjuvant 0 8 247 255 B-treatment
therapy 9 16 256 263 I-treatment
will 17 21 264 268 O
not 22 25 269 272 O
count 26 31 273 278 O
towards 32 39 279 286 O
prior 40 45 287 292 B-treatment
treatment 46 55 293 302 I-treatment
for 56 59 303 306 O
metastatic 60 70 307 317 B-cancer
disease 71 78 318 325 I-cancer
, 78 79 325 326 O
unless 80 86 327 333 O
the 87 90 334 337 O
patient 91 98 338 345 O
relapsed 99 107 346 354 O

Alanine 0 7 355 362 B-clinical_variable
aminotransferase 8 24 363 379 I-clinical_variable
( 25 26 380 381 I-clinical_variable
ALT 26 29 381 384 I-clinical_variable
) 29 30 384 385 I-clinical_variable
and 31 34 386 389 O
aspartate 35 44 390 399 B-clinical_variable
aminotransferase 45 61 400 416 I-clinical_variable
( 62 63 417 418 I-clinical_variable
AST 63 66 418 421 I-clinical_variable
) 66 67 421 422 I-clinical_variable
= 68 69 423 424 O
< 69 70 424 425 O
2.5 71 74 426 429 B-upper_bound
x 75 76 430 431 I-upper_bound
ULN 77 80 432 435 I-upper_bound

Any 0 3 436 439 O
ongoing 4 11 440 447 O
toxicity 12 20 448 456 O
from 21 25 457 461 O
prior 26 31 462 467 B-treatment
anti 32 36 468 472 I-treatment
- 36 37 472 473 I-treatment
cancer 37 43 473 479 I-treatment
therapy 44 51 480 487 I-treatment

Any 0 3 488 491 O
prior 4 9 492 497 B-treatment
treatment 10 19 498 507 I-treatment
with 20 24 508 512 I-treatment
gemcitabine 25 36 513 524 I-treatment

Any 0 3 525 528 O
prior 4 9 529 534 B-treatment
treatment 10 19 535 544 I-treatment
with 20 24 545 549 I-treatment
pazopanib 25 34 550 559 I-treatment
or 35 37 560 562 O
vascular 38 46 563 571 B-clinical_variable
endothelial 47 58 572 583 I-clinical_variable
growth 59 65 584 590 I-clinical_variable
factor 66 72 591 597 I-clinical_variable
( 73 74 598 599 I-clinical_variable
VEGF 74 78 599 603 I-clinical_variable
) 78 79 603 604 I-clinical_variable
or 80 82 605 607 O
vascular 83 91 608 616 B-treatment
endothelial 92 103 617 628 I-treatment
growth 104 110 629 635 I-treatment
factor 111 117 636 642 I-treatment
receptor 118 126 643 651 I-treatment
( 127 128 652 653 I-treatment
VEGFR)-targeting 128 144 653 669 I-treatment
agents 145 151 670 676 I-treatment
( 152 153 677 678 O
eg 153 155 678 680 O
. 155 156 680 681 O
sorafenib 157 166 682 691 B-treatment
, 166 167 691 692 O
sunitinib 168 177 693 702 B-treatment
, 177 178 702 703 O
and 179 182 704 707 O
bevacizumab 183 194 708 719 B-treatment
) 194 195 719 720 O

Any 0 3 721 724 O
serious 4 11 725 732 O
and/or 12 18 733 739 O
unstable 19 27 740 748 O
pre 28 31 749 752 O
- 31 32 752 753 O
existing 32 40 753 761 O
medical 41 48 762 769 B-chronic_disease
, 48 49 769 770 O
psychiatric 50 61 771 782 B-chronic_disease
, 61 62 782 783 O
or 63 65 784 786 O
other 66 71 787 792 O
condition 72 81 793 802 O
that 82 86 803 807 O
could 87 92 808 813 O
interfere 93 102 814 823 O
with 103 107 824 828 O
subject 108 115 829 836 O
's 115 117 836 838 O
safety 118 124 839 845 O
, 124 125 845 846 O
provision 126 135 847 856 O
of 136 138 857 859 O
informed 139 147 860 868 O
consent 148 155 869 876 O
, 155 156 876 877 O
or 157 159 878 880 O
compliance 160 170 881 891 O
to 171 173 892 894 O
study 174 179 895 900 O
procedures 180 190 901 911 O

Cardiac 0 7 912 919 B-treatment
angioplasty 8 19 920 931 I-treatment
or 20 22 932 934 O
stenting 23 31 935 943 B-treatment

Chemotherapy 0 12 944 956 B-treatment
, 12 13 956 957 O
immunotherapy 14 27 958 971 B-treatment
, 27 28 971 972 O
biologic 29 37 973 981 B-treatment
therapy 38 45 982 989 I-treatment
, 45 46 989 990 O
investigational 47 62 991 1006 B-treatment
therapy 63 70 1007 1014 I-treatment
or 71 73 1015 1017 O
hormonal 74 82 1018 1026 B-treatment
therapy 83 90 1027 1034 I-treatment

Childbearing 0 12 1035 1047 O
potential 13 22 1048 1057 O
, 22 23 1057 1058 O
including 24 33 1059 1068 O
any 34 37 1069 1072 O
female 38 44 1073 1079 B-gender
who 45 48 1080 1083 O
has 49 52 1084 1087 O
had 53 56 1088 1091 O
a 57 58 1092 1093 O
negative 59 67 1094 1102 B-pregnancy
serum 68 73 1103 1108 I-pregnancy
pregnancy 74 83 1109 1118 I-pregnancy
test 84 88 1119 1123 O

Class 0 5 1124 1129 B-lower_bound
III 6 9 1130 1133 I-lower_bound
or 10 12 1134 1136 O
IV 13 15 1137 1139 B-upper_bound
congestive 16 26 1140 1150 B-chronic_disease
heart 27 32 1151 1156 I-chronic_disease
failure 33 40 1157 1164 I-chronic_disease
, 40 41 1164 1165 O
as 42 44 1166 1168 O
defined 45 52 1169 1176 O
by 53 55 1177 1179 O
the 56 59 1180 1183 O
New 60 63 1184 1187 B-clinical_variable
York 64 68 1188 1192 I-clinical_variable
Heart 69 74 1193 1198 I-clinical_variable
Association 75 86 1199 1210 I-clinical_variable
( 87 88 1211 1212 I-clinical_variable
NYHA 88 92 1212 1216 I-clinical_variable
) 92 93 1216 1217 I-clinical_variable

Clinically 0 10 1218 1228 O
significant 11 22 1229 1240 O
gastrointestinal 23 39 1241 1257 B-chronic_disease
abnormalities 40 53 1258 1271 I-chronic_disease
that 54 58 1272 1276 O
may 59 62 1277 1280 O
affect 63 69 1281 1287 O
absorption 70 80 1288 1298 O
of 81 83 1299 1301 O
investigational 84 99 1302 1317 B-treatment
produc 100 106 1318 1324 I-treatment

Coronary 0 8 1325 1333 B-treatment
artery 9 15 1334 1340 I-treatment
bypass 16 22 1341 1347 I-treatment
graft 23 28 1348 1353 I-treatment
surgery 29 36 1354 1361 I-treatment

Corrected 0 9 1362 1371 B-clinical_variable
QT 10 12 1372 1374 I-clinical_variable
interval 13 21 1375 1383 I-clinical_variable
( 22 23 1384 1385 I-clinical_variable
QTc 23 26 1385 1388 I-clinical_variable
) 26 27 1388 1389 I-clinical_variable
> 28 29 1390 1391 O
480 30 33 1392 1395 B-lower_bound
milliseconds 34 46 1396 1408 I-lower_bound
( 47 48 1409 1410 I-lower_bound
msecs 48 53 1410 1415 I-lower_bound
) 53 54 1415 1416 I-lower_bound
using 55 60 1417 1422 O
Bazett 61 67 1423 1429 O
's 67 69 1429 1431 O
formula 70 77 1432 1439 O

Eastern 0 7 1440 1447 B-clinical_variable
Cooperative 8 19 1448 1459 I-clinical_variable
Oncology 20 28 1460 1468 I-clinical_variable
Group 29 34 1469 1474 I-clinical_variable
( 35 36 1475 1476 I-clinical_variable
ECOG 36 40 1476 1480 I-clinical_variable
) 40 41 1480 1481 I-clinical_variable
performance 42 53 1482 1493 I-clinical_variable
status 54 60 1494 1500 I-clinical_variable
of 61 63 1501 1503 O
0 64 65 1504 1505 B-lower_bound
- 65 66 1505 1506 O
2 66 67 1506 1507 B-upper_bound

Evidence 0 8 1508 1516 O
of 9 11 1517 1519 O
active 12 18 1520 1526 B-chronic_disease
bleeding 19 27 1527 1535 I-chronic_disease
or 28 30 1536 1538 O
bleeding 31 39 1539 1547 B-chronic_disease
diathesis 40 49 1548 1557 I-chronic_disease

Female 0 6 1558 1564 B-gender
subjects 7 15 1565 1573 I-gender
who 16 19 1574 1577 O
are 20 23 1578 1581 O
lactating 24 33 1582 1591 O
should 34 40 1592 1598 O
discontinue 41 52 1599 1610 O
nursing 53 60 1611 1618 O
prior 61 66 1619 1624 O
to 67 69 1625 1627 O
the 70 73 1628 1631 O
first 74 79 1632 1637 O
dose 80 84 1638 1642 O
of 85 87 1643 1645 O
study 88 93 1646 1651 B-treatment
drug 94 98 1652 1656 I-treatment
and 99 102 1657 1660 O
should 103 109 1661 1667 O
refrain 110 117 1668 1675 O
from 118 122 1676 1680 O
nursing 123 130 1681 1688 O
throughout 131 141 1689 1699 O
the 142 145 1700 1703 O
treatment 146 155 1704 1713 B-treatment
period 156 162 1714 1720 O

Hemoglobin 0 10 1721 1731 B-clinical_variable
> 11 12 1732 1733 O
= 12 13 1733 1734 O
9 14 15 1735 1736 B-lower_bound
g 16 17 1737 1738 I-lower_bound
/ 17 18 1738 1739 I-lower_bound
dL 18 20 1739 1741 I-lower_bound
( 21 22 1742 1743 I-lower_bound
5.6 22 25 1743 1746 I-lower_bound
mmol 26 30 1747 1751 I-lower_bound
/ 30 31 1751 1752 I-lower_bound
L 31 32 1752 1753 I-lower_bound
) 32 33 1753 1754 I-lower_bound

Hemoptysis 0 10 1755 1765 B-chronic_disease
in 11 13 1766 1768 O
excess 14 20 1769 1775 O
of 21 23 1776 1778 O
2.5 24 27 1779 1782 O
mL 28 30 1783 1785 O
( 31 32 1786 1787 O
or 32 34 1787 1789 O
one 35 38 1790 1793 O
half 39 43 1794 1798 O
teaspoon 44 52 1799 1807 O
) 52 53 1807 1808 O
within 54 60 1809 1815 O
8 61 62 1816 1817 B-upper_bound
weeks 63 68 1818 1823 I-upper_bound
of 69 71 1824 1826 O
first 72 77 1827 1832 O
dose 78 82 1833 1837 O
of 83 85 1838 1840 O
study 86 91 1841 1846 O
drug 92 96 1847 1851 O

Histologically 0 14 1852 1866 O
confirmed 15 24 1867 1876 O
diagnosis 25 34 1877 1886 O
of 35 37 1887 1889 O
metastatic 38 48 1890 1900 B-cancer
or 49 51 1901 1903 O
unresectable 52 64 1904 1916 O
soft 65 69 1917 1921 B-cancer
tissue 70 76 1922 1928 I-cancer
sarcoma 77 84 1929 1936 I-cancer
, 84 85 1936 1937 O
excluding 86 95 1938 1947 O
gastrointestinal 96 112 1948 1964 B-cancer
stromal 113 120 1965 1972 I-cancer
tumors 121 127 1973 1979 I-cancer
, 127 128 1979 1980 O
Kaposi 129 135 1981 1987 B-cancer
's 135 137 1987 1989 I-cancer
sarcoma 138 145 1990 1997 I-cancer
, 145 146 1997 1998 O
Ewing 147 152 1999 2004 B-cancer
's 152 154 2004 2006 I-cancer
family 155 161 2007 2013 I-cancer
of 162 164 2014 2016 I-cancer
tumors 165 171 2017 2023 I-cancer
, 171 172 2023 2024 O
and 173 176 2025 2028 O
embryonal 177 186 2029 2038 B-cancer
or 187 189 2039 2041 O
alveolar 190 198 2042 2050 B-cancer
rhabdomyosarcoma 199 215 2051 2067 I-cancer

History 0 7 2068 2075 O
of 8 10 2076 2078 O
abdominal 11 20 2079 2088 B-chronic_disease
fistula 21 28 2089 2096 I-chronic_disease
, 28 29 2096 2097 O
gastrointestinal 30 46 2098 2114 B-chronic_disease
perforation 47 58 2115 2126 I-chronic_disease
, 58 59 2126 2127 O
or 60 62 2128 2130 O
intra 63 68 2131 2136 B-chronic_disease
- 68 69 2136 2137 I-chronic_disease
abdominal 69 78 2137 2146 I-chronic_disease
abscess 79 86 2147 2154 I-chronic_disease

History 0 7 2155 2162 O
of 8 10 2163 2165 O
any 11 14 2166 2169 O
one 15 18 2170 2173 O
or 19 21 2174 2176 O
more 22 26 2177 2181 O
of 27 29 2182 2184 O
the 30 33 2185 2188 O
following 34 43 2189 2198 O
cardiovascular 44 58 2199 2213 B-chronic_disease
conditions 59 69 2214 2224 O

History 0 7 2225 2232 O
of 8 10 2233 2235 O
cerebrovascular 11 26 2236 2251 B-chronic_disease
accident 27 35 2252 2260 I-chronic_disease
including 36 45 2261 2270 O
transient 46 55 2271 2280 B-chronic_disease
ischemic 56 64 2281 2289 I-chronic_disease
attack 65 71 2290 2296 I-chronic_disease
( 72 73 2297 2298 I-chronic_disease
TIA 73 76 2298 2301 I-chronic_disease
) 76 77 2301 2302 I-chronic_disease
, 77 78 2302 2303 O
pulmonary 79 88 2304 2313 B-chronic_disease
embolism 89 97 2314 2322 I-chronic_disease
or 98 100 2323 2325 O
untreated 101 110 2326 2335 O
deep 111 115 2336 2340 B-chronic_disease
venous 116 122 2341 2347 I-chronic_disease
thrombosis 123 133 2348 2358 I-chronic_disease
( 134 135 2359 2360 I-chronic_disease
DVT 135 138 2360 2363 I-chronic_disease
) 138 139 2363 2364 I-chronic_disease

History 0 7 2365 2372 O
or 8 10 2373 2375 O
clinical 11 19 2376 2384 O
evidence 20 28 2385 2393 O
of 29 31 2394 2396 O
central 32 39 2397 2404 B-cancer
nervous 40 47 2405 2412 I-cancer
system 48 54 2413 2419 I-cancer
( 55 56 2420 2421 I-cancer
CNS 56 59 2421 2424 I-cancer
) 59 60 2424 2425 I-cancer
metastases 61 71 2426 2436 I-cancer
or 72 74 2437 2439 O
leptomeningeal 75 89 2440 2454 B-cancer
carcinomatosis 90 104 2455 2469 I-cancer
, 104 105 2469 2470 O
except 106 112 2471 2477 O
for 113 116 2478 2481 O
individuals 117 128 2482 2493 O
who 129 132 2494 2497 O
have 133 137 2498 2502 O
previously 138 148 2503 2513 O
- 148 149 2513 2514 O
treated 149 156 2514 2521 O
CNS 157 160 2522 2525 B-cancer
metastases 161 171 2526 2536 I-cancer
, 171 172 2536 2537 O
are 173 176 2538 2541 O
asymptomatic 177 189 2542 2554 O

Implants 0 8 2555 2563 O
of 9 11 2564 2566 O
levonorgestrel 12 26 2567 2581 B-treatment

Inflammatory 0 12 2582 2594 B-chronic_disease
bowel 13 18 2595 2600 I-chronic_disease
disease 19 26 2601 2608 I-chronic_disease
( 27 28 2609 2610 O
e.g. 28 32 2610 2614 O
ulcerative 33 43 2615 2625 B-chronic_disease
colitis 44 51 2626 2633 I-chronic_disease
, 51 52 2633 2634 O
Crohn 53 58 2635 2640 B-chronic_disease
's 58 60 2640 2642 I-chronic_disease
disease 61 68 2643 2650 I-chronic_disease
) 68 69 2650 2651 O
, 69 70 2651 2652 O
or 71 73 2653 2655 O
other 74 79 2656 2661 O
gastrointestinal 80 96 2662 2678 B-chronic_disease
conditions 97 107 2679 2689 I-chronic_disease
with 108 112 2690 2694 O
increased 113 122 2695 2704 O
risk 123 127 2705 2709 O
of 128 130 2710 2712 O
perforation 131 142 2713 2724 B-chronic_disease

Injectable 0 10 2725 2735 B-treatment
progesterone 11 23 2736 2748 I-treatment

Intrauterine 0 12 2749 2761 B-contraception_consent
device 13 19 2762 2768 I-contraception_consent
( 20 21 2769 2770 I-contraception_consent
IUD 21 24 2770 2773 I-contraception_consent
) 24 25 2773 2774 I-contraception_consent
or 26 28 2775 2777 O
intrauterine 29 41 2778 2790 B-contraception_consent
system 42 48 2791 2797 I-contraception_consent
( 49 50 2798 2799 I-contraception_consent
IUS 50 53 2799 2802 I-contraception_consent
) 53 54 2802 2803 I-contraception_consent
with 55 59 2804 2808 O
a 60 61 2809 2810 O
documented 62 72 2811 2821 O
failure 73 80 2822 2829 O
rate 81 85 2830 2834 O
of 86 88 2835 2837 O
less 89 93 2838 2842 O
than 94 98 2843 2847 O
1 99 100 2848 2849 B-upper_bound
% 100 101 2849 2850 I-upper_bound
per 102 105 2851 2854 I-upper_bound
year 106 110 2855 2859 I-upper_bound

Known 0 5 2860 2865 O
endobronchial 6 19 2866 2879 B-cancer
lesions 20 27 2880 2887 I-cancer
and/or 28 34 2888 2894 O
lesions 35 42 2895 2902 O
infiltrating 43 55 2903 2915 O
major 56 61 2916 2921 O
pulmonary 62 71 2922 2931 O
vessels 72 79 2932 2939 O
that 80 84 2940 2944 O
increase 85 93 2945 2953 O
the 94 97 2954 2957 O
risk 98 102 2958 2962 O
of 103 105 2963 2965 O
pulmonary 106 115 2966 2975 B-chronic_disease
hemorrhage 116 126 2976 2986 I-chronic_disease

Known 0 5 2987 2992 O
intraluminal 6 18 2993 3005 B-cancer
metastatic 19 29 3006 3016 I-cancer
lesion 30 36 3017 3023 O
/ 36 37 3023 3024 O
s 37 38 3024 3025 O
with 39 43 3026 3030 O
risk 44 48 3031 3035 O
of 49 51 3036 3038 O
bleeding 52 60 3039 3047 O

Major 0 5 3048 3053 B-treatment
resection 6 15 3054 3063 I-treatment
of 16 18 3064 3066 O
the 19 22 3067 3070 O
stomach 23 30 3071 3078 O
or 31 33 3079 3081 O
small 34 39 3082 3087 O
bowel 40 45 3088 3093 O

Malabsorption 0 13 3094 3107 B-chronic_disease
syndrome 14 22 3108 3116 I-chronic_disease

Male 0 4 3117 3121 B-gender
partner 5 12 3122 3129 O
sterilization 13 26 3130 3143 B-treatment
( 27 28 3144 3145 O
vasectomy 28 37 3145 3154 B-treatment
with 38 42 3155 3159 O
documentation 43 56 3160 3173 O
of 57 59 3174 3176 O
azoospermia 60 71 3177 3188 B-chronic_disease
) 71 72 3188 3189 O
prior 73 78 3190 3195 O
to 79 81 3196 3198 O
the 82 85 3199 3202 O
female 86 92 3203 3209 B-gender
subject 93 100 3210 3217 I-gender
's 100 102 3217 3219 I-gender
entry 103 108 3220 3225 O
into 109 113 3226 3230 O
the 114 117 3231 3234 O
study 118 123 3235 3240 O
, 123 124 3240 3241 O
and 125 128 3242 3245 O
this 129 133 3246 3250 O
male 134 138 3251 3255 O
is 139 141 3256 3258 O
the 142 145 3259 3262 O
sole 146 150 3263 3267 O
partner 151 158 3268 3275 O
for 159 162 3276 3279 O
that 163 167 3280 3284 O
subject 168 175 3285 3292 O

Measurable 0 10 3293 3303 O
disease 11 18 3304 3311 O
per 19 22 3312 3315 O
Response 23 31 3316 3324 B-treatment
Evaluation 32 42 3325 3335 I-treatment
Criteria 43 51 3336 3344 I-treatment
in 52 54 3345 3347 I-treatment
Solid 55 60 3348 3353 I-treatment
Tumors 61 67 3354 3360 I-treatment
( 68 69 3361 3362 I-treatment
RECIST 69 75 3362 3368 I-treatment
) 75 76 3368 3369 I-treatment
1.1 77 80 3370 3373 I-treatment

Myocardial 0 10 3374 3384 B-chronic_disease
infarction 11 21 3385 3395 I-chronic_disease

Oral 0 4 3396 3400 B-contraception_consent
contraceptive 5 18 3401 3414 I-contraception_consent
, 18 19 3414 3415 O
either 20 26 3416 3422 O
combined 27 35 3423 3431 O
or 36 38 3432 3434 O
progesterone 39 51 3435 3447 O
alone 52 57 3448 3453 O

Patients 0 8 3454 3462 O
must 9 13 3463 3467 O
have 14 18 3468 3472 O
received 19 27 3473 3481 O
at 28 30 3482 3484 O
least 31 36 3485 3490 O
one 37 40 3491 3494 B-lower_bound
, 40 41 3494 3495 O
but 42 45 3496 3499 O
not 46 49 3500 3503 O
more 50 54 3504 3508 O
than 55 59 3509 3513 O
three 60 65 3514 3519 B-upper_bound
, 65 66 3519 3520 O
systemic 67 75 3521 3529 B-treatment
regimens 76 84 3530 3538 I-treatment
for 85 88 3539 3542 O
treatment 89 98 3543 3552 B-treatment
of 99 101 3553 3555 O
metastatic 102 112 3556 3566 B-cancer
soft 113 117 3567 3571 I-cancer
tissue 118 124 3572 3578 I-cancer
sarcoma 125 132 3579 3586 I-cancer

Percutaneous 0 12 3587 3599 B-contraception_consent
contraceptive 13 26 3600 3613 I-contraception_consent
patches 27 34 3614 3621 I-contraception_consent

Platelets 0 9 3622 3631 B-clinical_variable
> 10 11 3632 3633 O
= 11 12 3633 3634 O
100 13 16 3635 3638 B-lower_bound
x 17 18 3639 3640 I-lower_bound
10 19 21 3641 3643 I-lower_bound
^ 21 22 3643 3644 I-lower_bound
9 22 23 3644 3645 I-lower_bound
/ 23 24 3645 3646 I-lower_bound
L 24 25 3646 3647 I-lower_bound

Poorly 0 6 3648 3654 O
controlled 7 17 3655 3665 O
hypertension 18 30 3666 3678 B-chronic_disease
( 31 32 3679 3680 O
defined 32 39 3680 3687 O
as 40 42 3688 3690 O
systolic 43 51 3691 3699 B-clinical_variable
blood 52 57 3700 3705 I-clinical_variable
pressure 58 66 3706 3714 I-clinical_variable
( 67 68 3715 3716 I-clinical_variable
SBP 68 71 3716 3719 I-clinical_variable
) 71 72 3719 3720 I-clinical_variable

Presence 0 8 3721 3729 O
of 9 11 3730 3732 O
uncontrolled 12 24 3733 3745 B-chronic_disease
infection 25 34 3746 3755 I-chronic_disease

Prior 0 5 3756 3761 B-treatment
major 6 11 3762 3767 I-treatment
surgery 12 19 3768 3775 I-treatment
or 20 22 3776 3778 O
trauma 23 29 3779 3785 B-chronic_disease

Prior 0 5 3786 3791 O
malignancy 6 16 3792 3802 B-cancer

Prothrombin 0 11 3803 3814 B-clinical_variable
time 12 16 3815 3819 I-clinical_variable
( 17 18 3820 3821 I-clinical_variable
PT 18 20 3821 3823 I-clinical_variable
) 20 21 3823 3824 I-clinical_variable
or 22 24 3825 3827 O
international 25 38 3828 3841 B-clinical_variable
normalized 39 49 3842 3852 I-clinical_variable
ratio 50 55 3853 3858 I-clinical_variable
( 56 57 3859 3860 I-clinical_variable
INR 57 60 3860 3863 I-clinical_variable
) 60 61 3863 3864 I-clinical_variable
= 62 63 3865 3866 O
< 63 64 3866 3867 O
1.2 65 68 3868 3871 B-upper_bound
x 69 70 3872 3873 I-upper_bound
upper 71 76 3874 3879 I-upper_bound
limit 77 82 3880 3885 I-upper_bound
of 83 85 3886 3888 I-upper_bound
normal 86 92 3889 3895 I-upper_bound
( 93 94 3896 3897 I-upper_bound
ULN 94 97 3897 3900 I-upper_bound
) 97 98 3900 3901 I-upper_bound

Radiation 0 9 3902 3911 B-treatment
therapy 10 17 3912 3919 I-treatment
, 17 18 3919 3920 O
surgery 19 26 3921 3928 B-treatment
or 27 29 3929 3931 O
tumor 30 35 3932 3937 B-treatment
embolization 36 48 3938 3950 I-treatment

Serum 0 5 3951 3956 B-clinical_variable
creatinine 6 16 3957 3967 I-clinical_variable
= 17 18 3968 3969 O
< 18 19 3969 3970 O
1.5 20 23 3971 3974 B-upper_bound
mg 24 26 3975 3977 I-upper_bound
/ 26 27 3977 3978 I-upper_bound
dL 27 29 3978 3980 I-upper_bound
( 30 31 3981 3982 I-upper_bound
133 31 34 3982 3985 I-upper_bound
umol 35 39 3986 3990 I-upper_bound
/ 39 40 3990 3991 I-upper_bound
L 40 41 3991 3992 I-upper_bound
) 41 42 3992 3993 I-upper_bound

Subjects 0 8 3994 4002 O
not 9 12 4003 4006 O
using 13 18 4007 4012 O
hormone 19 26 4013 4020 B-treatment
replacement 27 38 4021 4032 I-treatment
therapy 39 46 4033 4040 I-treatment
( 47 48 4041 4042 I-treatment
HRT 48 51 4042 4045 I-treatment
) 51 52 4045 4046 I-treatment
must 53 57 4047 4051 O
have 58 62 4052 4056 O
experienced 63 74 4057 4068 O
total 75 80 4069 4074 O
cessation 81 90 4075 4084 O
of 91 93 4085 4087 O
menses 94 100 4088 4094 O

Subjects 0 8 4095 4103 O
using 9 14 4104 4109 O
HRT 15 18 4110 4113 B-treatment
must 19 23 4114 4118 O
have 24 28 4119 4123 O
experienced 29 40 4124 4135 O
total 41 46 4136 4141 O
cessation 47 56 4142 4151 B-chronic_disease
of 57 59 4152 4154 I-chronic_disease
menses 60 66 4155 4161 I-chronic_disease

Symptomatic 0 11 4162 4173 O
peripheral 12 22 4174 4184 B-chronic_disease
vascular 23 31 4185 4193 I-chronic_disease
disease 32 39 4194 4201 I-chronic_disease

Total 0 5 4202 4207 O
bilirubin 6 15 4208 4217 B-clinical_variable
= 16 17 4218 4219 O
< 17 18 4219 4220 O
1.5 19 22 4221 4224 B-upper_bound
x 23 24 4225 4226 I-upper_bound
ULN 25 28 4227 4230 I-upper_bound

Unable 0 6 4231 4237 O
or 7 9 4238 4240 O
unwilling 10 19 4241 4250 O
to 20 22 4251 4253 O
discontinue 23 34 4254 4265 O
use 35 38 4266 4269 O
of 39 41 4270 4272 O
prohibited 42 52 4273 4283 O
medications 53 64 4284 4295 B-treatment

Unstable 0 8 4296 4304 B-chronic_disease
angina 9 15 4305 4311 I-chronic_disease

Urine 0 5 4312 4317 B-clinical_variable
protein 6 13 4318 4325 I-clinical_variable
to 14 16 4326 4328 I-clinical_variable
creatinine 17 27 4329 4339 I-clinical_variable
ratio 28 33 4340 4345 I-clinical_variable
( 34 35 4346 4347 I-clinical_variable
UPC 35 38 4347 4350 I-clinical_variable
) 38 39 4350 4351 I-clinical_variable
< 40 41 4352 4353 O
1 42 43 4354 4355 B-upper_bound

administration 0 14 4356 4370 O
of 15 17 4371 4373 O
any 18 21 4374 4377 O
non 22 25 4378 4381 O
- 25 26 4381 4382 O
oncologic 26 35 4382 4391 O
investigational 36 51 4392 4407 B-treatment
drug 52 56 4408 4412 I-treatment

concomitant 0 11 4413 4424 O
elevations 12 22 4425 4435 O
in 23 25 4436 4438 O
bilirubin 26 35 4439 4448 B-clinical_variable
and 36 39 4449 4452 O
AST 40 43 4453 4456 B-clinical_variable
/ 43 44 4456 4457 O
ALT 44 47 4457 4460 B-clinical_variable
above 48 53 4461 4466 O
1.0 54 57 4467 4470 B-lower_bound
x 58 59 4471 4472 I-lower_bound
ULN 60 63 4473 4476 I-lower_bound
( 64 65 4477 4478 I-lower_bound
upper 65 70 4478 4483 I-lower_bound
limit 71 76 4484 4489 I-lower_bound
of 77 79 4490 4492 I-lower_bound
normal 80 86 4493 4499 I-lower_bound
) 86 87 4499 4500 I-lower_bound
are 88 91 4501 4504 O
not 92 95 4505 4508 O
permitted 96 105 4509 4518 O

for 0 3 4519 4522 O
14 4 6 4523 4525 B-upper_bound
days 7 11 4526 4530 I-upper_bound
before 12 18 4531 4537 I-upper_bound
exposure 19 27 4538 4546 O
to 28 30 4547 4549 O
investigational 31 46 4550 4565 B-treatment
product 47 54 4566 4573 I-treatment
, 54 55 4573 4574 O
through 56 63 4575 4582 O
the 64 67 4583 4586 O
dosing 68 74 4587 4593 O
period 75 81 4594 4600 O

for 0 3 4601 4604 O
14 4 6 4605 4607 B-upper_bound
days 7 11 4608 4612 I-upper_bound
following 12 21 4613 4622 O
the 22 25 4623 4626 O
last 26 30 4627 4631 O
dose 31 35 4632 4636 O
of 36 38 4637 4639 O
study 39 44 4640 4645 O
drug 45 49 4646 4650 O

for 0 3 4651 4654 O
6 4 5 4655 4656 B-upper_bound
months 6 12 4657 4663 I-upper_bound
prior 13 18 4664 4669 I-upper_bound
to 19 21 4670 4672 O
first 22 27 4673 4678 O
dose 28 32 4679 4683 O
of 33 35 4684 4686 O
study 36 41 4687 4692 B-treatment
drug 42 46 4693 4697 I-treatment

for 0 3 4698 4701 O
> 4 5 4702 4703 O
= 5 6 4703 4704 O
1 7 8 4705 4706 B-lower_bound
year 9 13 4707 4711 I-lower_bound
and 14 17 4712 4715 O
be 18 20 4716 4718 O
greater 21 28 4719 4726 O
than 29 33 4727 4731 O
45 34 36 4732 4734 B-lower_bound
years 37 42 4735 4740 I-lower_bound
in 43 45 4741 4743 O
age 46 49 4744 4747 B-age

for 0 3 4748 4751 O
> 4 5 4752 4753 O
= 5 6 4753 4754 O
1 7 8 4755 4756 B-lower_bound
year 9 13 4757 4761 I-lower_bound
and 14 17 4762 4765 O
be 18 20 4766 4768 O
greater 21 28 4769 4776 O
than 29 33 4777 4781 O
45 34 36 4782 4784 B-lower_bound
years 37 42 4785 4790 I-lower_bound
of 43 45 4791 4793 O
age 46 49 4794 4797 B-age

for 0 3 4798 4801 O
at 4 6 4802 4804 O
least 7 12 4805 4810 O
14 13 15 4811 4813 B-lower_bound
days 16 20 4814 4818 I-lower_bound
or 21 23 4819 4821 O
five 24 28 4822 4826 B-lower_bound
half 29 33 4827 4831 I-lower_bound
- 33 34 4831 4832 I-lower_bound
lives 34 39 4832 4837 I-lower_bound
of 40 42 4838 4840 I-lower_bound
a 43 44 4841 4842 I-lower_bound
drug 45 49 4843 4847 I-lower_bound
( 50 51 4848 4849 O
whichever 51 60 4849 4858 O
is 61 63 4859 4861 O
longer 64 70 4862 4868 O
) 70 71 4868 4869 O

for 0 3 4870 4873 O
at 4 6 4874 4876 O
least 7 12 4877 4882 O
21 13 15 4883 4885 B-lower_bound
days 16 20 4886 4890 I-lower_bound
after 21 26 4891 4896 O
the 27 30 4897 4900 O
last 31 35 4901 4905 O
dose 36 40 4906 4910 O
of 41 43 4911 4913 O
investigational 44 59 4914 4929 B-treatment
product 60 67 4930 4937 I-treatment

for 0 3 4938 4941 O
at 4 6 4942 4944 O
least 7 12 4945 4950 O
6 13 14 4951 4952 B-lower_bound
weeks 15 20 4953 4958 I-lower_bound
are 21 24 4959 4962 O
eligible 25 33 4963 4971 O

have 0 4 4972 4976 O
had 5 8 4977 4980 O
documented 9 19 4981 4991 O
evidence 20 28 4992 5000 O
of 29 31 5001 5003 O
menopause 32 41 5004 5013 O
based 42 47 5014 5019 O
on 48 50 5020 5022 O
FSH 51 54 5023 5026 B-treatment
and 55 58 5027 5030 O
estradiol 59 68 5031 5040 B-clinical_variable
concentrations 69 83 5041 5055 I-clinical_variable
prior 84 89 5056 5061 O
to 90 92 5062 5064 O
initiation 93 103 5065 5075 O
of 104 106 5076 5078 O
HRT 107 110 5079 5082 B-treatment

have 0 4 5083 5087 O
had 5 8 5088 5091 O
no 9 11 5092 5094 O
requirement 12 23 5095 5106 O
for 24 27 5107 5110 O
steroids 28 36 5111 5119 B-treatment
or 37 39 5120 5122 O
anti 40 44 5123 5127 B-treatment
- 44 45 5127 5128 I-treatment
seizure 45 52 5128 5135 I-treatment
medication 53 63 5136 5146 I-treatment

must 0 4 5147 5151 O
be 5 7 5152 5154 O
willing 8 15 5155 5162 O
to 16 18 5163 5165 O
comply 19 25 5166 5172 O
with 26 30 5173 5177 O
treatment 31 40 5178 5187 B-treatment
and 41 44 5188 5191 O
follow 45 51 5192 5198 O
- 51 52 5198 5199 O
up 52 54 5199 5201 O

patients 0 8 5202 5210 O
must 9 13 5211 5215 O
have 14 18 5216 5220 O
had 19 22 5221 5224 O
a 23 24 5225 5226 O
prior 25 30 5227 5232 B-treatment
anthracycline 31 44 5233 5246 I-treatment
in 45 47 5247 5249 O
either 48 54 5250 5256 O
the 55 58 5257 5260 O
adjuvant 59 67 5261 5269 O
or 68 70 5270 5272 O
metastatic 71 81 5273 5283 B-cancer
setting 82 89 5284 5291 O
unless 90 96 5292 5298 O
medically 97 106 5299 5308 O
inappropriate 107 120 5309 5322 O
for 121 124 5323 5326 O
the 125 128 5327 5330 O
patient 129 136 5331 5338 O

presence 0 8 5339 5347 O
of 9 11 5348 5350 O
any 12 15 5351 5354 O
non 16 19 5355 5358 B-chronic_disease
- 19 20 5358 5359 I-chronic_disease
healing 20 27 5359 5366 I-chronic_disease
wound 28 33 5367 5372 I-chronic_disease
, 33 34 5372 5373 O
fracture 35 43 5374 5382 B-chronic_disease
, 43 44 5382 5383 O
or 45 47 5384 5386 O
ulcer 48 53 5387 5392 B-chronic_disease
( 54 55 5393 5394 O
procedures 55 65 5394 5404 O
such 66 70 5405 5409 O
as 71 73 5410 5412 O
catheter 74 82 5413 5421 B-treatment
placement 83 92 5422 5431 I-treatment
not 93 96 5432 5435 O
considered 97 107 5436 5446 O
to 108 110 5447 5449 O
be 111 113 5450 5452 O
major 114 119 5453 5458 O

prior 0 5 5459 5464 B-treatment
to 6 8 5465 5467 I-treatment
the 9 12 5468 5471 I-treatment
first 13 18 5472 5477 I-treatment
dose 19 23 5478 5482 I-treatment
of 24 26 5483 5485 I-treatment
study 27 32 5486 5491 I-treatment
drug 33 37 5492 5496 I-treatment
and 38 41 5497 5500 O
for 42 45 5501 5504 O
the 46 49 5505 5508 O
duration 50 58 5509 5517 O
of 59 61 5518 5520 O
the 62 65 5521 5524 O
study 66 71 5525 5530 O

subjects 0 8 5531 5539 O
may 9 12 5540 5543 O
not 13 16 5544 5547 O
have 17 21 5548 5552 O
had 22 25 5553 5556 O
a 26 27 5557 5558 O
transfusion 28 39 5559 5570 B-treatment
within 40 46 5571 5577 O
7 47 48 5578 5579 B-upper_bound
days 49 53 5580 5584 I-upper_bound
of 54 56 5585 5587 O
screening 57 66 5588 5597 O
assessment 67 77 5598 5608 O

subjects 0 8 5609 5617 O
must 9 13 5618 5622 O
have 14 18 5623 5627 O
a 19 20 5628 5629 O
24 21 23 5630 5632 B-clinical_variable
- 23 24 5632 5633 I-clinical_variable
hour 24 28 5633 5637 I-clinical_variable
urine 29 34 5638 5643 I-clinical_variable
protein 35 42 5644 5651 I-clinical_variable
value 43 48 5652 5657 I-clinical_variable
< 49 50 5658 5659 O
1 51 52 5660 5661 B-upper_bound
g 53 54 5662 5663 I-upper_bound
to 55 57 5664 5666 O
be 58 60 5667 5669 O
eligible 61 69 5670 5678 O

subjects 0 8 5679 5687 O
who 9 12 5688 5691 O
have 13 17 5692 5696 O
had 18 21 5697 5700 O
another 22 29 5701 5708 O
malignancy 30 40 5709 5719 B-cancer
and 41 44 5720 5723 O
have 45 49 5724 5728 O
been 50 54 5729 5733 O
disease 55 62 5734 5741 O
- 62 63 5741 5742 O
free 63 67 5742 5746 O

subjects 0 8 5747 5755 O
with 9 13 5756 5760 O
a 14 15 5761 5762 O
history 16 23 5763 5770 O
of 24 26 5771 5773 O
completely 27 37 5774 5784 O
resected 38 46 5785 5793 O
non 47 50 5794 5797 B-cancer
- 50 51 5797 5798 I-cancer
melanomatous 51 63 5798 5810 I-cancer
skin 64 68 5811 5815 I-cancer
carcinoma 69 78 5816 5825 I-cancer
, 78 79 5825 5826 O
successfully 80 92 5827 5839 O
treated 93 100 5840 5847 O
in 101 103 5848 5850 B-cancer
situ 104 108 5851 5855 I-cancer
carcinoma 109 118 5856 5865 I-cancer
, 118 119 5865 5866 O
or 120 122 5867 5869 O
successfully 123 135 5870 5882 O
treated 136 143 5883 5890 O
bladder 144 151 5891 5898 B-cancer
cancer 152 158 5899 5905 I-cancer
are 159 162 5906 5909 O
eligible 163 171 5910 5918 O

subjects 0 8 5919 5927 O
with 9 13 5928 5932 O
recent 14 20 5933 5939 O
DVT 21 24 5940 5943 B-chronic_disease
who 25 28 5944 5947 O
have 29 33 5948 5952 O
been 34 38 5953 5957 O
treated 39 46 5958 5965 O
with 47 51 5966 5970 O
therapeutic 52 63 5971 5982 B-treatment
anti 64 68 5983 5987 I-treatment
- 68 69 5987 5988 I-treatment
coagulating 69 80 5988 5999 I-treatment
agents 81 87 6000 6006 I-treatment

use 0 3 6007 6010 O
of 4 6 6011 6013 O
urine 7 12 6014 6019 B-treatment
dipstick 13 21 6020 6028 I-treatment
for 22 25 6029 6032 O
renal 26 31 6033 6038 O
function 32 40 6039 6047 O
assessment 41 51 6048 6058 O
is 52 54 6059 6061 O
not 55 58 6062 6065 O
acceptable 59 69 6066 6076 O

within 0 6 6077 6083 O
1 7 8 6084 6085 B-upper_bound
year 9 13 6086 6090 I-upper_bound
of 14 16 6091 6093 O
completing 17 27 6094 6104 O
adjuvant 28 36 6105 6113 B-treatment
therapy 37 44 6114 6121 I-treatment

within 0 6 6122 6128 O
14 7 9 6129 6131 B-upper_bound
days 10 14 6132 6136 I-upper_bound
or 15 17 6137 6139 O
five 18 22 6140 6144 O
half 23 27 6145 6149 O
- 27 28 6149 6150 O
lives 28 33 6150 6155 O
of 34 36 6156 6158 O
a 37 38 6159 6160 O
drug 39 43 6161 6165 O
( 44 45 6166 6167 O
whichever 45 54 6167 6176 O
is 55 57 6177 6179 O
longer 58 64 6180 6186 O
) 64 65 6186 6187 O
prior 66 71 6188 6193 O
to 72 74 6194 6196 O
the 75 78 6197 6200 O
first 79 84 6201 6206 O
dose 85 89 6207 6211 O
of 90 92 6212 6214 O
pazopanib 93 102 6215 6224 B-treatment

within 0 6 6225 6231 O
14 7 9 6232 6234 B-upper_bound
days 10 14 6235 6239 I-upper_bound
prior 15 20 6240 6245 I-upper_bound
to 21 23 6246 6248 O
the 24 27 6249 6252 O
first 28 33 6253 6258 O
dose 34 38 6259 6263 O
of 39 41 6264 6266 O
pazopanib 42 51 6267 6276 B-treatment

within 0 6 6277 6283 O
28 7 9 6284 6286 B-upper_bound
days 10 14 6287 6291 I-upper_bound
prior 15 20 6292 6297 I-upper_bound
to 21 23 6298 6300 O
beginning 24 33 6301 6310 O
study 34 39 6311 6316 B-treatment
treatment 40 49 6317 6326 I-treatment

within 0 6 6327 6333 O
28 7 9 6334 6336 B-upper_bound
days 10 14 6337 6341 I-upper_bound
prior 15 20 6342 6347 I-upper_bound
to 21 23 6348 6350 O
first 24 29 6351 6356 O
dose 30 34 6357 6361 O
of 35 37 6362 6364 O
study 38 43 6365 6370 B-treatment
drug 44 48 6371 6375 I-treatment

within 0 6 6376 6382 O
30 7 9 6383 6385 B-upper_bound
days 10 14 6386 6390 I-upper_bound
or 15 17 6391 6393 O
5 18 19 6394 6395 B-upper_bound
half 20 24 6396 6400 I-upper_bound
- 24 25 6400 6401 I-upper_bound
lives 25 30 6401 6406 I-upper_bound
whichever 31 40 6407 6416 O
is 41 43 6417 6419 O
longer 44 50 6420 6426 O
prior 51 56 6427 6432 O
to 57 59 6433 6435 O
receiving 60 69 6436 6445 O
the 70 73 6446 6449 O
first 74 79 6450 6455 O
dose 80 84 6456 6460 O
of 85 87 6461 6463 O
study 88 93 6464 6469 B-treatment
treatment 94 103 6470 6479 I-treatment

within 0 6 6480 6486 O
7 7 8 6487 6488 B-upper_bound
days 9 13 6489 6493 I-upper_bound
prior 14 19 6494 6499 I-upper_bound
to 20 22 6500 6502 O
the 23 26 6503 6506 O
first 27 32 6507 6512 O
dose 33 37 6513 6517 O
of 38 40 6518 6520 O
study 41 46 6521 6526 B-treatment
treatment 47 56 6527 6536 I-treatment

within 0 6 6537 6543 O
the 7 10 6544 6547 O
past 11 15 6548 6552 B-upper_bound
6 16 17 6553 6554 I-upper_bound
months 18 24 6555 6561 I-upper_bound

